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Abstract
Background: Alu methylation is correlated with the overall level of DNA methylation and recombination activity of
the genome. However, the maintenance and methylation status of each CpG site within Alu elements (Alu) and its
methylation status have not well characterized. This information is useful for understanding natural status of Alu in
the genome and helpful for developing an optimal assay to quantify Alu hypomethylation.
Methods: Bisulfite clone sequencing was carried out in 14 human gastric samples initially. A Cac8I COBRA-DHPLC
assay was developed to detect methylated-Alu proportion in cell lines and 48 paired gastric carcinomas and 55
gastritis samples. DHPLC data were statistically interpreted using SPSS version 16.0.
Results: From the results of 427 Alu bisulfite clone sequences, we found that only 27.2% of CpG sites within Alu
elements were preserved (4.6 of 17 analyzed CpGs, A ~ Q) and that 86.6% of remaining-CpGs were methylated.
Deamination was the main reason for low preservation of methylation targets. A high correlation coefficient of
methylation was observed between Alu clones and CpG site J (0.963), A (0.950), H (0.946), D (0.945). Comethylation
of the sites H and J were used as an indicator of the proportion of methylated-Alu in a Cac8I COBRA-DHPLC assay.
Validation studies showed that hypermethylation or hypomethylation of Alu elements in human cell lines could be
detected sensitively by the assay after treatment with 5-aza-dC and M.SssI, respectively. The proportion of
methylated-Alu copies in gastric carcinomas (3.01%) was significantly lower than that in the corresponding normal
samples (3.19%) and gastritis biopsies (3.23%).
Conclusions: Most Alu CpG sites are deaminated in the genome. 27% of Alu CpG sites represented in our
amplification products. 87% of the remaining CpG sites are methylated. Alu hypomethylation in primary gastric
carcinomas could be detected with the Cac8I COBRA-DHPLC assay quantitatively.
Background
The Alu element is a member of the SINE family of
repetitive elements. It is an example of a non-automatic
retrotransposon. It is the most abundant gene in the
human genome (more than one million copies per hap-
loid genome), representing 10% of the genome mass [1].
Alu elements are mainly distributed in gene-rich
regions. About 75% of gene promoters in the genome
contain Alu elements [2].
Ac o n s e n s u sAlu element usually contains 24 CpG
sites (Figure 1) [3]. In fact, the CpGs within Alu ele-
ments harbour up to one-third of the total CpG sites in
the genome [4,5]. In normal tissues most Alu elements
are methylated and transcriptionally inactive. However,
stress-induced demethylation of these CpGs could reac-
tivate Alu transcription. Although Alu transcripts
encode no protein, they can regulate expression of other
genes, affect recombination, and influence patterns of
nucleosome formation and evolution of the genome
[6-9]. Demethylation of Alu elements is an indicator of
lower genome stability, which is necessary for gene
recombination and chromosome translocation [10]. Ret-
rotranscriptase encoded by LINE-1 helps retrotranscrip-
tion and transposition of Alu elements into the genome
* Correspondence: dengdajun@bjmu.edu.cn
† Contributed equally
Key Laboratory of Carcinogenesis and Translational Research (Ministry of
Education), Beijing Cancer Hospital and Institute, Peking University School of
Oncology, Fu-Cheng-Lu, No.52, Haidian District, Beijing, 100142, China
Xiang et al. BMC Cancer 2010, 10:44
http://www.biomedcentral.com/1471-2407/10/44
© 2010 Xiang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
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LINE-1 sequences is highly correlated with global DNA
methylation content [12]. Estimation of total methyla-
tion content of Alu elements is useful for evaluation of
the global genomic methylation status and level of
homologous and non-homologous chromatin recombi-
nation in gene-rich regions.
Deamination and other variations of CpGs within Alu
elements happen frequently during evolution. This has
led to diversification of Alu into 213 subfamilies [13].
However, the maintenance and methylation status at
each CpG site within Alu has not been characterized
experimentally. Several methods such as the combined
bisulfite restriction assay (COBRA), pyrosequencing,
MethyLight and unmethylated Alu-specific amplification
have been developed in the past few years [14-16]. In
those assays, methylation content of a specific CpG site
(s) within Alu elements was detected and used to repre-
sent the methylation/demethylation level of all Alu ele-
ments. However, representativity and consistency of
methylation status of these used CpG sites have not
been investigated. Additionally it is not known how
representative or reproducible are the results for these
previously studied CpG sites. In the present study, initi-
ally we analyzed the maintenance status and variations,
including deamination, at each CpG site, in human can-
cer and normal tissues. Finally, the methylation status of
each CpG site was then evaluated based upon extensive
Figure 1 Illustration of the genomic organization (A), methylation, and deamination (B) of CpG sites within Alu. The 17 CpG sites are
marked with the capital letters (A-Q) above the Alu consensus sequence (Ref. [15]) and highlighted in the colour pink. The arrowed-line point to
the recognition sequence (including the sites H and J) of restriction enzyme Cac8I; Rectangles, primer matching sequences; The arrowed-boxes,
primer F-1, F-2, and R-1 were used to amplify the bisulfite-converted templates, and F-w and R-w were used to amplify the templates without
bisulfite treatment. The primer F-2 and R-1 were the same as described (Ref. [14]). The sites A-B-C were included within the probe sequence of
MethyLight (Ref. [15]). The sites H-I-J were the target CpGs in pyrosequencing assay and the site P was the target CpG in MboI-COBRA (Ref. [14]).
The site M was the target CpG used for quantification of unmethylated Alu (Ref. [16]). The capital letter T in the colour pink was resulted from
evolutionary deamination of cytosine. The underlined CpG and TpA represent the methylated CpG site and antisense-deaminated CpG site,
respectively.
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Page 2 of 11bisulfite clone sequencings. Based upon the analysis of
the correlation between the number of methylated CpGs
and the methylation status of each CpG site within Alu
elements, a novel convenient COBRA-DHPLC assay was
developed to quantify changes of the proportion of
methylated-Alu elements in human gastric carcinomas
successfully.
Methods
Human gastric mucosa samples
Forty-eight pairs of primary gastric carcinoma (GC) sur-
gical tissues and their corresponding normal (GC-Nor)
samples, 55 gastric biopsies from patients with or with-
out gastritis, were collected from inpatients and outpati-
ents at Beijing Cancer Hospital, respectively (male/
female sex ratio, 7/3; 40-81 years old, the average age
60-y). All these specimens were freshly frozen at -70°C.
The Institutional Review Boards of Peking University
School of Oncology approved the study and all patients
gave written informed consent.
Cell lines and treatment of 5-aza-dC
Human carcinoma cell lines AGS and SW480 were cul-
tured in F12 and DMEM medium (GIBCO) supplemen-
ted with 10% FBS at 37°C, 5% CO2. These cell lines
were treated with 10 μmol/L (final concentration) of 5-
aza-dC (Sigma) or an equal volume of PBS (pH7.4, 5 μl/
well with 500 μl medium) for 72 hours, individually.
DNA extraction and bisulfite modification
Genomic DNA was extracted from tissue samples with
phenol/chloroform as described [17]. The unmethylated-
cytosines of the genomic DNA were converted to uri-
dines by addition of 5 mol/L of sodium bisulfite at 50°C
overnight [18].
Modification with M.SssI
Genomic DNA (0.1 μg/μl) of AGS and SW480 cell lines
was treated with M.SssI methylase (final concentration,
1U / μg DNA; New England Biolabs) and 0.16 mmol/L
of S-adenosylmethionine (SAM) at 37°C overnight.
Amplification of Alu elements by PCR
Three sets of primers were used and illustrated in
Figure 1A. The primer sequences of R-1 and F-2 were
the same as described [14]. Other primers were designed
according to the Alu consensus sequence [15]. The uni-
versal primer set-1 (F-1: 5’-TTtg taatT TTagT aTttt
gggag gT-3’; R-1: 5’-gatcc ccaAA ctAAaA tAcaA tAA-3’)
was used to amplify a 224-bp Alu fragment (including
17 CpG sites from site A-Q) using the bisulfite-modified
templates by PCR-1 [30 μl reaction including 50 ng
DNA templates, 0.15 mmol/L of dNTP, 0.15 μmol/L of
each primer, 0.9 U of HotStar Taq DNA polymerase
(Qiagen GmbH, Hilden, Germany); thermal cycler con-
ditions: 95°C for 15 min ® (95°C for 30 s ® 60°C for
30 s ® 72°C for 30 s) × 37 cycles ® 72°C for 10 min].
The universal primer set-2, consisting of the primer F-2
(5’-gatct TtTta Ttaaa aataT aaaaa ttagT-3’)a n dt h e
a b o v ep r i m e rR - 1w a su s e dt oa m p l i f ya1 5 6 - b pf r a g -
ment (including 12 CpG sites: Site F-Q) with the bisul-
fite-modified templates by PCR-2 [thermal cycle
condition: 95°C for 15 min ® (95°C for 30 s ® 52.8°C
for 30 s ® 72°C for 30 s) × 37 cycles ® 72°C for
10 min] as described [14]. Both the primer set-1 and
set-2 contain a number of T (or A) in the forward pri-
mers (or reversed primer), with which only bisulfite-
modified templates could be amplified. The primer set-
w( F w :5 ’-gcctg taatc ccagc act-3’;R w :5 ’-aggct ggagt
gcagt gg-3’) was used to amplify a 237-bp Alu fragment
from genomic DNA without bisulfite modification by
PCR-W. The reaction mixture was the same as the
PCR-1 [thermal cycler conditions: 95°C for 15 min ®
(95°C for 30 sec ® 60°C for 30 sec ® 72°C for 30 sec) ×
37 cycles ® 72°C for 10 min].
Cloning and sequencing
Above PCR-1, PCR-2 and PCR-w products were cloned
into TA-vector and sequenced by ABI 3730 Analyzer.
The average number of the sequenced TA clones was
30 for each sample.
Cac8I CORBA of the PCR-2 products
After bisulfite conversion, the 156-bp PCR-2 products of
methylated Alu templates contain a 5’-GCgnGCg-
3’sequence (including CpG sites H and J), that can be
digested by Cac8I (Figure 1A). Thus, Cac8I digestion
was used to develop the COBRA assay for detection of
Alu methylation. The PCR-2 products (10 μL) were
digested with 2 U of Cac8I (New England Biolabs) at
37°C for 6 hours. The 156-bp methylated Alu was cut
into 112-bp and 44-bp fragments by Cac8I, whereas the
unmethylated Alu was not cut because these cleavage
positions did not exist after bisulfite modification. The
digested PCR products were further analyzed directly by
DHPLC without purification. Equal amount of PCR-2
products of a fully methylated Alu clone was used as
the standard Cac8I digestion control in every COBRA
experiments. Fully cut of all of the standard control pro-
ducts was used as the indicator of the complete diges-
tion of tested samples.
Separation and quantification of methylated- and
unmethylated-Alu by DHPLC
The Cac8I cut methylated-Alu and uncut unmethylated-
Alu fragments in the PCR-2 digestion were separated
with the WAVE DNA Fragment Analysis System
(Transgenomic, Inc., Om a h a ,U S A )a t4 8 ° C ,t h e
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double-stranded DNA fragments amplified from bisul-
fite-modified templates as described previously [19,20],
and detected by fluorescence (FL)-detector [21]. The
WAVE-HS1 FL-dye buffer (Transgenomic, Inc.) was
used to enhance the FL-intensity of PCR products (uni-
versal post-column labelling). The apparent total methy-
lated-Alu proportion in tested samples was calculated
according to the ratio of the peak height for the 112-bp
methylated fragment to the total peak height of both the
methylated and 156-bp unmethylated fragment peaks.
The peak height of the unmethylated-Alu PCR products
was 81.22% of that for the Cac8I digested methylated-
Alu PCR products at equal molecule number. Therefore
81.22% was the constant used to adjust the measured
peak height for the methylated-Alu.
Data and statistical analysis
The Student’s t-test was used to analyze the average
methylation frequency of each CpG site within the
sequenced clones and the total methylated-Alu propor-
tion in different groups of gastric mucosa samples. The
SPSS 16.0 software was used for these statistical ana-
lyses. Significance was defined as p < 0.05. The correla-
tion coefficient between methylation of each CpG site
and the methylated-Alu was calculated.
Results and Discussions
Analysis of methylation and mutation status of each CpG
site within Alu elements in human gastric samples by
bisulfite clone sequencing
The methylation status of each CpG site within the full-
length Alu elements in both cancer and normal tissues
has not previously been reported. Therefore, we carried
out extensive bisulfite clone sequencing of the 224-bp
PCR-1 products amplified with the primer set-1
(Figure 1A). The PCR-1 products, including 17 CpG
sites (A ~ Q), were amplified from bisulfite-modified
templates of 14 gastric mucosa samples [including 5
pairs of GCs and GC-Nor tissues, and 4 normal gastric
mucosa biopsies], cloned, and sequenced (about 30
clones per sample). Results showed that the methylation
frequencies were quite variable among different CpG
sites (7.1% ~ 33.9%). Compared with the GC-Nor sam-
ples, hypomethylation in GC samples was not observed
among all of 17 CpG sites when sequencing. The aver-
age methylation rate of these 17 CpG sites was 22.7% in
normal biopsy control, 23.3% in GC-Nor, 24.6% in GC
(Table 1). Both the lowest methylation rate and highest
positive rates of other kinds of mutations were observed
at the sites I and L (Table 1 and Figure 2A). A signifi-
cant difference of CpG retention rate was observed at
the site L between GC-Nor and normal control samples
(P = 0.022).
Cytosine deamination at CpG sites, especially at the
methylated-CpG sites, is a frequent event during evolu-
tion of Alu elements. The deamination on the antisense
strand (antisense-deamination, CpA) was represented as
TpA in the bisulfite-modified sequences specifically
(Figure 1B). Significant difference in the antisense-dea-
mination rate was found only at the site O when com-
paring the GC-Nor and normal samples (34.4% vs.
22.6%, p = 0.046), but not at any site when comparing
the GC and GC-Nor (Table 1). These results suggest
that the total antisense-deamination level in Alu ele-
ments was not significantly changed during carcinogen-
esis. Therefore, the results of total 427 sequenced clones
were pooled together for further analysis.
Price et al. extracted about 480,000 Alu elements via a
BLAST search of the human genome and sub-classified
them into 213 subfamilies [13]. Using the same data, we
did a bioinformatic analysis of the maintenance and var-
iation status at each CpG site within Alu elements.
According to this analysis, we found that the average
rate of retention of the 17 CpG sites within Alu was up
to 89.7% and that average rates of antisense-deamination
(CpA), sense-deamination (TpG) and other variations
were only 3.1%, 4.6%, and 2.7%, respectively (Figure 2C).
However, in the present study, the average antisense-
deamination rate was up to 30.2% among the 472 bisul-
fite-clones (Table 1). To study whether the high deami-
nation rate in the tested samples was resulted from
bisulfite modification bias, we carried out clone sequen-
cing of Alu elements in one representative pair of GC
and GC-Nor samples without bisulfite modification with
the primer set-w (Figure 1A and Figure 2B). The results
showed the average rate of deamination between the
GC (27 clones) and GC-Nor (29 clones) samples was
similar: 24.8% and 27.6% for the antisense strand, and
23.5% and 24.5% for the sense strand in the GC and
GC-Nor sample, respectively. These results were consis-
tent with 30.2% antisense-deamination rate among the
427 clones. Thus, bisulfite mod i f i c a t i o nb i a si su n l i k e l y
the reason of high deamination rate in the genome
observed in the present study.
Yang et al. also reported that based upon sequence
analysis of 15 bisulfite clones almost two-thirds of the
CpG sites in Alu elements are mutated [14]. The primer
set-1 used in the bisulfite clone sequencing covers
470,988 of the extracted 476,152 Alu elements (98.9%).
Among the 427 Alu clones, 69.3%, 18.5%, and 12.2% are
AluS, AluY,a n dAluJ, respectively (Table 2). These
results are similar to the values observed both in the
extracted Alu database in the genome (73.7%, 20.1%,
and 6.2%) and in the primer set-1 matched Alu subfami-
lies in the database (73.6%, 19.3%, and 6.1%). Moreover,
among the 222 methylated Alu clones (with number of
methylated-CpGs ≥ 4), proportions of methylated AluS,
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Page 5 of 11AluY,a n dAluJ are 70.3%, 23.4%, and 6.3%, respectively
(Table 2). Thus, the possible PCR-1 bias, if any, may not
result in favouring amplification of certain kinds of Alu
subfamilies, especially for the methylated Alu elements.
Because methylation-independent CpG-free primers are
favouring the amplification of unmethylated (and evolu-
tionary deaminated) sequences generally, we could not
exclude that PCR bias for GC-poor Alu elements might
lead to the result of low prevalence of CpG sites within
Alu elements in the present study. The bias is likely
unavoidable during amplification of the diversified Alu
elements with PCR.
Selection of methylated-CpG sites correlated well with
methylated-Alu
Based on the sequencing results of the above 427 clones,
we found that the average frequency of methylated CpG
at each CpG site (based on the consensus Alu sequence)
was 23.6%; TpG sites, 33.8%; TpA sites, 30.2%; other
kinds of mutations, 12.5% (Table 1). TpG sites represent
both the unmethylated CpGs modified with bisulfite and
the evolutionary sense-deaminated CpGs. In the case of
the average frequency of sense-deamination equal to
that of antisense-deamination, as demonstrated with
sequencing of the PCR-w products, the frequency of
unmethylated CpG on each CpG site was 3.6% (the dif-
ference of 33.8% and 30.2%). It means that only 27.2%
[the sum of 23.6% and 3.6%] of Alu CpG sites is
retained (4.62 CpG sites/clone) and that 86.6% (23.6% of
27.2%) of the remaining methylation target-CpG sites
within Alu elements are methylated in the genome.
We further analyzed the distribution of frequencies of
clones with different numbers of methylated-CpG sites;
and found that 31% of clones (n = 133) contained 0~2
methylated CpG sites and 52% of clones (n = 222) con-
tained 4~14 methylated CpG sites (Figure 3A, left).
Figure 2 Proportion of methylation and variations at each CpG site within Alu elements. The average proportion of methylation (CpG),
deamination of CpG on the antisense strand (TpA), demethylation and deamination of CpG on the sense strand (TpG), and other variations at
each CpG site among a total of 427 bisulfite clones from 14 tested gastric samples is illustrated (A). Maintenance, deamination on the sense
strand (TpG) and antisense strand (CpA) at each CpG site were analyzed based on 56 tested clone sequences from a gastric mucosa sample
without bisulfite modification (B) and on 476,152 copies of Alu elements extracted from the NCBI database of the human genome (C) as
described bioinformatically (Ref. [13]).
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Page 6 of 11Based on the phenomenon that the number of methy-
lated CpG sites in clones is negatively correlated with
the number of both TpG and TpA in the same clones,
respectively (Figure 3A right, and 3B), we conclude that
it is the deamination on the sense and antisense strands,
but not demethylation nor unmethylation, is the con-
tributory factor to the low number of methylated CpG
sites within these clones.
For localization of the CpG sites with good represen-
tation of methylation of Alu elements, the correlation of
methylation status between each CpG site and the
completely tested fragment of Alu was then calculated.
When the clones contain 0-2 and ≥ 4m e t h y l a t e d - C p G
sites were defined as the unmethylated and methylated
Alu, respectively, the top four correlation coefficients
were 0.963 for the site J, 0.950 for the site A, 0.946 for
t h es i t eH ,a n d0 . 9 4 5f o rt h es i t eD .T h eb o t t o mf o u r
were 0.072 for the site I, 0.446 for the site L, 0.677 for
the site O, and 0.692 for the site P (Additional file 1,
Table S1). Apparently, the site P, which was used as the
restriction site in the MboI COBRA assay [14], may not
be a good detecting target. The combined coefficient
Table 2 Bioinformatic analysis of Content and distribution of Alu subfamilies among the PCR-1 and PCR-2 products
Table legend text.
Alu
subfamily
Bioinformatic analysis with the database
a Analysis of bisulfite clone sequencings
Average
CpG no.
b
Copy no.
of Alu
Copy no. of Alu
matched to the
primers for PCR-1
Clone no. of Alu
obtained in the
PCR-1 products
Total clone no. of Alu with
methylated-CpG number ≥ 4i n
the PCR-1 products
Clone no. of Alu
obtained in the
PCR-2 products
c
AluJ 16.3 29508 (6.2%) 28889 (6.1%) 52 (12.2%) 14 (6.3%) 3 (5.6%)
AluS 22.4 350888 (73.7%) 350419 (73.6%) 296 (69.3%) 156 (70.3%) 30 (55.6%)
AluY 24.5 95756 (20.1%) 91680 (19.3%) 79 (18.5%) 52 (23.4%) 21 (38.9%)
(Total) 22.4 476152 (100%) 470988 (100%) 427 (100%) 222 (100%) 54 (100%)
a476152 copies of Alu elements extracted bioinformatically from the NCBI database of human genome (C) as described (Ref. [13]);
bwithin the full sequence of Alu elements as illustrated in Figure 1A;
camplified from two representative samples with the primer set-2 after bisulfite modification
Figure 3 Distribution of bisulfite Alu clones with different methylated-CpG number and variations at CpG sites.T h ea c c u m u l a t e d
proportion of bisulfite clones with different number of methylated-CpGs (A, left), and the constituent ratio of various dinucleotides at the 17
CpG sites of Alu clones (A, right). The distribution of the number of CpG, TpG, TpA, and other variations among Alu clones from bisulfite-treated
templates with a different number of methylated-CpGs was illustrated (B).
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Page 7 of 11was 0.849 for the sites A-B-C, which was used as
MethyLight probe sequence [15], and 0.708 for the sites
H and J, which was used in pyrosequencing [14].
Development of a COBRA-DHPLC assay to quantify the
proportion of methylated-Alu copies
Although the combined coefficients for the sites A-B-C
and H&J were lower than their individual coefficients
(Additional file 1, Table S1), it is reasonable to expect
that comethylation of these CpG sites might have a
higher representativity for methylated-Alu than for a
single CpG methylation. In fact, the specificity of detec-
tion of the proportion of methylated-Alu by comethyla-
tion of the sites A-B-C or H&J was up to 100%, whereas
for individual CpG methylation it was lower: 97.0% for
the site J, 95.5% for the site H, 93.2% for the site A, and
90.2% for the site D, if the Alu clones contained 0~2
methylated CpG sites were considered as unmethylated-
Alu. Thus, we used the strategy of detection of
comethylation of the sites H&J to develop the following
quantitative assay.
As mentioned above, pyrosequencing was previously
used to detect Alu methylation at H-I-J sites [14]. How-
ever, unlike molecule-based multiple CpG sites-assays
(i.e. clones or PCR copies) such as methylation-specific
PCR, MethyLight, DHPLC, and clone sequencing, pyro-
sequencing is not a molecule-based assay, as it only pro-
vides information on the proportion of methylation at
individually tested CpG site in the pooled Alu elements.
The pyrosequencing results for different CpG sites
might represent different Alu copies, respectively, thus
should not be considered as a molecule-based assay.
COBRA is one of the most convenient methods for
detection of DNA methylation. When more than one
CpG site is included in the restriction sequence,
COBRA is also a molecule-based multiple CpG sites-
assay, which could be used to detect methylated Alu
copies among the genome.
To develop a COBRA assay suitable for various kinds
of sample storages, such as paraffin embedded tissues,
the optimal size of PCR amplicon should be less than
200-bp and a single restriction site should be selected
for analysis. However, we could not find a restriction
enzyme with a single cut site for the sites A, D, H, and J
within the PCR-1 products. Therefore, the primer set-2
was used to amplify the 156-bp PCR-2 product that
contains both H and J sites and could be digested by
Cac8I (recognition site, 5’-GCN^NGC-3’) when the tem-
plate is methylated (Figure 1A). The PCR-2 products
comethylated at both the sites H and J contain a
5’-GCg^nGCg-3’ sequence, thus can be digested into
112-bp and 44-bp fragments by Cac8I (Figure 1A and
4A). Results of clone sequencing of the PCR-2 products
from two representative samples showed that the primer
set-2 was likely favouring the amplification of AluY
clones (38%), which remain more methylation targets
than AluS and AluJ (Table 2).
The traditional COBRA assay is gel-based and could
only be used to detect target CpG methylation hemi-
quantitatively. DHPLC is a typical separation and quan-
tification method that could also be used to detect DNA
fragments and methylation of CpG islands, whether or
n o ti ti sc o m b i n e dw i t ho t h e ra s s a y s( 1 9 , 2 0 , 2 2 ) .T o
detect the methylated-Alu proportion accurately,
DHPLC was used to separate and quantify the Cac8I-
cut (112-bp, methylated) and -uncut (156-bp, unmethy-
lated) fragments. The methylated- and unmethylated-
Alu in the digestion could be separated by DHPLC
under the completely non-denaturing temperature 48°C.
The retention time for the methylated- and unmethy-
lated-Alu peak was 3.3 and 4.7 min, respectively. A lin-
ear relationship over a wide range could be observed
between the loading concentration (1/1~1/64) and ratio
of peak height for the methylated-Alu products (y =
0.9912x, R
2 = 0.995) (Figure 4B). The detection limit of
this assay was about 3.4 × 10
6 copies of methylated Alu
elements (the total copy number of Alu within one
diploid cell is 2 × 10
6). The coefficient of variation (CV)
of this assay was 7.4%. Because of the very high specifi-
city (100%) of comethylation at both the sites H and J
for the methylated Alu, we used ratio of the 112-bp
methylated Alu peak to the sum of the methylated and
156-bp unmethylated Alu peaks to represent the propor-
tion of the methylated Alu copies in the tested samples,
as described on the method section.
Both hypomethylation of Alu elements in 5-aza-dC
treated AGS (2.12% ® 1.90%) or SW480 cell lines
(2.28% ® 1.88%) and hypermethylation of Alu elements
in M.SssI-methylated DNA templates (2.26% ® 2.44%
for AGS; 2.21% ® 2.55% for SW480) could sensitively
be detected by the Cac8I COBRA-DHPLC assay suc-
cessfully (Figure 4C). It was reported that global geno-
mic 5-methylcytosine content in the human genome
was tissue-specific with a range of 3.43-4.26% of cyto-
sine residues methylated in normal tissues (15,23,24).
We used the Cac8I COBRA-DHPLC method to detect
the methylated-Alu proportion in 48 pairs of GCs and
GC-Nor and 55 gastric mucosa biopsy samples from
noncancerous patients. Results showed that the average
methylated-Alu proportion in GCs (%, mean ± SD, 3.01
± 0.25) was significantly lower than that in GC-Nor
(3.19 ± 0.31) (Figure 5; P <0 . 0 1 )a n dt h a ti ng a s t r i c
biopsies from patients without tumor (3.23 ± 0.57; P <
0.001; data not shown). We did not observed any signifi-
cant association between the methylated-Alu proportion
in GCs and patients’ clinical-pathological characteristics,
such as lymph node metastasis, age, and sex (data not
s h o w n ) .T h i sr e s u l ti sc o n s i s t e n tw i t ht h eh y p o t h e s i s
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Page 8 of 11Figure 5 Comparison of proportion of methylated-Alu in primary gastric carcinomas and the corresponding normal samples by the
Cac8I COBRA-DHPLC assay. Bisulfite modified Alu elements in 48 pairs of gastric carcinomas (GC) and the corresponding normal tissues (GC-
Nor) with or without lymph node metastasis (M+/M-) were amplified with the primer set-2. The 156-bp PCR-2 products of Alu elements were
digested with Cac8I at 37°C for 6 hours. The methylated-Alu was cut and the unmethylated-Alu was not cut by Cac8I. The digested PCR-2
products were separated by DHPLC at the undenatured temperature 48°C. The proportion of methylated-Alu was calculated according to ratio of
the adjusted peak height for the methylated-Alu to that for the unmethylated-Alu. Hypomethylation was observed in 33 of 48 of GCs and
marked with the colour blue.
Figure 4 Chromatography of Cac8I digestion of methylated and unmethylated PCR-2 products. The electrophoresis image of the PCR-2
products of methylated- and unmethylated-Alu clones with and without Cac8I digestion (A); DHPLC chromatography of Cac8I digested products
after the methylated-Alu PCR-2 products was diluted with the unmethylated Alu PCR-2 products at various ratios (B); After 5-aza-dC treatment (10
μM) or M.SssI-modification, changes of the methylated-Alu proportion could be detected by the Cac8I COBRA-DHPLC assay sensitively (C). Open
arrow and gray arrow point to peaks that correspond to the methylated- and unmethylated-Alu fragments, respectively. The gray square area is
the single direction magnified part of open dash-line enclosed area.
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Page 9 of 11that globe hypomethylation of the genome is an early
event during carcinogenesis [25-28].
Conclusions
Most Alu CpG sites are deaminated in the genome. 27%
of Alu CpG sites represented in our amplification pro-
ducts. 87% of the remaining CpG sites are methylated.
Based on the analysis of extensive bisulfite clone
sequencings, a Cac8I COBRA-DHPLC assay was devel-
oped to quantify sensitively the methylated-Alu propor-
tion. Hypomethylation of Alu elements was observed in
gastric carcinomas with the assay.
Additional file 1: Table S1. - Correlation coefficients of methylation
status between each CpG site and Alu clone subgroups with
various methylated CpGs. All of 427 Alu clones were classified into
different subgroups according to the methylated-CpG number. Average
methylation frequency of each CpG site within each Alu subgroup was
calculated (methylated-CpG number of the CpG site to the clone
number of Alu within the subgroup). The correlation coefficient was
calculated for each CpG site based on the corresponding average
methylation frequency within each subgroup and the total methylated-
CpG number within the subgroup.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2407-10-
44-S1.XLS]
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